×
×

Cambridge Healthtech Institute (CHI) is closely monitoring the continuing developments on COVID-19. Currently, there is no plan to cancel or postpone any scheduled CHI meetings. CHI is tracking all travel restrictions issued by the European Centre for Disease Prevention and Control, as well as information and guidance from the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). We will provide further updates as events warrant.

PLENARY KEYNOTE SPEAKERS


Diane Blumenthal, PhD

Gene Therapy Manufacturing and Technical Development

Diane Blumenthal, PhD
Head, Technical Development, Spark Therapeutics

Ralf Schumacher, PhD

Current Opportunities and Challenges in Biotherapeutic CMC

Ralf Schumacher, PhD
Global Head, Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG



KEYNOTE SPEAKERS


Gerald Gellermann, PhD

Gerald Gellermann, PhD
Senior Fellow, Analytical Development, Novartis

Nicolas P. Mermod, PhD

Nicolas P. Mermod, PhD
Professor & Director, Biology & Medicine, University of Lausanne

Massimo Morbidelli, PhD

Massimo Morbidelli, PhD
Professor, Chemical and Bioengineering, ETH Zurich

Florence Salmon, PhD

Florence Salmon, PhD
Portfolio Lead Regulatory Affairs CMC, Cell and Gene Therapies, Novartis Pharma AG

Schmidt_Stefan

Stefan R. Schmidt, PhD
MBA, COO, Head, Operations, BioAtrium AG

Riccardo Torosantucci, PhD

Riccardo Torosantucci, PhD
Section Head, Formulation and Process Development, Sanofi-Aventis

Anne Tscheließnig, PhD

Anne Tscheließnig, PhD
Head, Downstream Development II, Biopharma Process Science Austria, Boehringer Ingelheim

James Warren, PhD

James Warren, PhD
Vice President, Pharmaceutical Development, Ultragenyx



Premier Sponsors






Join The Community at Bioprocessing Summit Europe


Download the Bioprocessing Summit Europe 2020 Brochure
Click Here

View prospectus & attendee breakdown
View details

Final Weeks to Register
Register now

Hear industry updates straight from bioprocess innovators
Learn more